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Abstract
Background: HIV infection can be treated effectively with antiretroviral agents, but the persistence of a latent
reservoir of integrated proviruses prevents eradication of HIV from infected individuals. The chromosomal
environment of integrated proviruses has been proposed to influence HIV latency, but the determinants of
transcriptional repression have not been fully clarified, and it is unclear whether the same molecular mechanisms
drive latency in different cell culture models.
Results: Here we compare data from five different in vitromodels of latency based on primary human T cells or a T
cell line. Cells were infected in vitro and separated into fractions containing proviruses that were either expressed or
silent/inducible, and integration site populations sequenced from each. We compared the locations of 6,252
expressed proviruses to those of 6,184 silent/inducible proviruses with respect to 140 forms of genomic annotation,
many analyzed over chromosomal intervals of multiple lengths. A regularized logistic regression model linking
proviral expression status to genomic features revealed no predictors of latency that performed better than chance,
though several genomic features were significantly associated with proviral expression in individual models.
Proviruses in the same chromosomal region did tend to share the same expressed or silent/inducible status if they
were from the same cell culture model, but not if they were from different models.
Conclusions: The silent/inducible phenotype appears to be associated with chromosomal position, but the
molecular basis is not fully clarified and may differ among in vitromodels of latency.
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Background
Highly active antiretroviral therapy (HAART) can sup-
press HIV-1 replication in infected patients, but the abil-
ity of HIV to persist as an inducible reservoir of latent
proviruses [1-3] obstructs eradication of the virus and
functional cure [4]. These latent proviruses are long lived
[5,6] and relatively invisible to the immune system [2,7].
The potential for even a single virus to restart infection
despite successful antiviral therapy means that it may be
necessary to eliminate all latent proviruses to eradicate
HIV from an infected person.
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After integration, a positive feedback loop of Tat trans-
activation appears to partition proviral gene activity into
either of two stable states [8-10]—abundant Tat driving
high proviral expression or little Tat leading to quies-
cent latency. Similar to the positional effect variega-
tion observed in fruit fly chromosomal rearrangements
[11,12], studies on cell clones with single integrations
show that differing integration sites can have large differ-
ences in proviral expression [13-15]. These data suggest
that integration site location, along with the cellular envi-
ronment [15-18], influences the balance between latency
and proviral expression.
Associations between latency and genomic features
have also been reported in collections of integration sites
from cell culture models although the consistency of these
effects across model systems and their relationships to
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latency in patients remains uncertain. Lewinski et al.
[19] reported that proviruses integrated in gene deserts,
alphoid repeats and highly expressed genes are more
likely to have low expression. Shan et al. [20] reported
an association between latency and integration in the
same transcriptional orientation as host genes. Pace
et al. [21] found that silent and expressed provirus inte-
gration sites differed in the abundance and expression
levels of nearby genes, GC content, CpG islands and
alphoid repeats. In model systems with defined inte-
gration sites, Lenasi et al. [22] reported decreased and
Han et al. [23] reported increased viral transcription
when the provirus is downstream of a highly expressed
host gene.
Cell-based models of latency are important for many
aspects of HIV research, including screening small
molecules that can reverse latency and potentially allow
eradication [24,25]. Location-driven differences in expres-
sion are preserved even after DNA methyltransferase and
histone deacetylase inhibitor treatments [13], which sug-
gests that integration location has the potential to con-
found “shock and kill” anti-latency treatments [26,27].
A greater understanding of the effects of integration
site location on latency could thus affect antiretroviral
development.
To search for features of integration site associated with
latency, we generated a set of inducible and expressed
integration sites using a primary central memory CD4+
T cell model of latency [28,29], collected four previ-
ously reported integration site datasets and modeled
the effects of genomic features near the integration site
on the expression status of these proviruses. Although
some genomic features associated with latency in indi-
vidual models, no feature was consistently associated
with proviral expression across all five cell culture mod-
els. However, closely neighboring proviruses within the
same cellular model shared the same latency status
much more often than expected by chance suggest-
ing that chromosomal position of integration affects
latency but that the mechanism remains unclear or dif-
fers between cell culture models. Thus these data help
inform the design of experiments in HIV eradication
research.
Results
The combination of integration site data newly reported
here (set named “Central Memory CD4+”) with previ-
ously published data (sets named “Jurkat”, “Bcl-2 trans-
duced CD4+”, “Active CD4+ & Resting CD4+”) provides
a collection of 12,436 integration sites (Table 1) where
the expression status of the provirus—silent/inducible or
expressed—is known. In three of the datasets, Jurkat,
Central Memory CD4+ and Bcl-2 transduced CD4+,
the proviruses were sorted based on inducibility. In the
Resting CD4+ and Active CD4+ datasets, cells were
sorted only based on proviral expression. Previous stud-
ies have shown that most silent proviruses in this model
system are inducible [30].
Global model
If a genomic feature and latency are monotonically related
then we should be able to detect this relationship using
Spearman rank correlation. In addition if a feature has a
consistent effect across models we should see a consis-
tent pattern in the direction of correlation. A simple first
look for correlation between genomic features (Table 2)
and latency status yielded inconsistent results among the
five samples with no variables having a significant Spear-
man rank correlation across all, or even four out of five,
of the samples (Figure 1). This suggests that there is not
a consistent simple monotonic relationship between the
genomic variable and latency, or that any such correlations
are modest and not detectable across all studies given
the available statistical power. We return to some of the
stronger trends below.
To investigate whether a combination of variables may
affect latency, we fit a lasso-regularized logistic regression,
as implemented in the R package glmnet [39], to pre-
dict latency using the genomic variables. The relationship
between silent/inducible status and each genomic vari-
able was allowed to vary between models by including
the interaction of genomic features with dummy variables
indicating cellular model. The λ smoothing parameter of
the lasso regression was optimized by finding the λ with
lowest classification error in 480-fold cross validation and
finding the simplest model with misclassification error
within one standard error.
The proportion of silent/inducible sites varied between
the samples. To avoid the model overfitting on this source
of variation, an indicator variable for each sample was
included in the base model. The base model with no
genomic variables was selected as the best model by
cross validation (Figure 2A). This suggest that there is
not a consistent linear relationship between an additive
combination of genomic variables and latency across all
models.
When each dataset was fit individually with leave-
one-out cross validation, improvements in cross-validated
misclassification error were only observed in the Active
CD4+ (5.8% decrease in misclassification error, standard
error: 2.1) and Jurkat (6.7% decrease in misclassification
error, standard error: 3.5) samples (Figure 2B-F). There
was no overlap in variables selected for the Active CD4+
and Jurkat samples.
Finding little global association between latency and
genomic features, we investigated whether predictors of
latency reported previously by single studies were consis-
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Active CD4+ Primary active
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HIV NL4-3 3 days 454 High vs. low Gag [21] 1604
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T cells






Sherrill-Mix et al. Retrovirology 2013, 10:90 Page 4 of 14
http://www.retrovirology.com/content/10/1/90
Table 2 Genomic data available for comparison to HIV integration sites
Group Type Source Number Types
T cell expression RNA-Seq Unpublished 1 RNA
Jurkat expression RNA-Seq Encode [31] 1 wgEncodeHudsonalphaRnaSeq
Integration sites Locations Unpublished 1 Sites
DNase sensitivity DNA-Seq/peaks Encode [31] 1 wgEncodeOpenChromDnase
Methylation DNA-Seq [32] 1 Methyl
CpG Locations UCSC [33] 1 cpgIslandExt
Sequence-based Continuous — 4 % GC, HIV PWM score, distance to centrosome,
chromosomal position
Repeats Locations UCSC [33] 16 DNA, LINE, Low_complexity, LTR, Other, RC,
RNA, rRNA, Satellite, scRNA, Simple_repeat, SINE,
snRNA, srpRNA, tRNA, alphoid
Histone acetylation ChIP-Seq/Peaks [34] 18 H2AK5ac, H2AK9ac, H2BK120ac, H2BK12ac,
H2BK20ac, H2BK5ac, H3K14ac, H3K18ac, H3K23ac,
H3K27ac, H3K36ac, H3K4ac, H3K9ac, H4K12ac,
H4K16ac, H4K5ac, H4K8ac, H4K91ac
Histone methylation and
other proteins
ChIP-Seq/Peaks [35] 23 CTCF, H2AZ, H2BK5me1, H3K27me1, H3K27me2,
H3K27me3, H3K36me1, H3K36me3, H3K4me1,
H3K4me2, H3K4me3, H3K79me1, H3K79me2,
H3K79me3, H3K9me1, H3K9me2, H3K9me3,
H3R2me1, H3R2me2, H4K20me1, H4K20me3,
H4R3me2, PolII
Chromatin state Binary [59] 51 State1,state2,. . . ,state51




Nucleosome ChIP-Seq [37] 2 Resting-Nucleosomes, Active-Nucleosomes
UCSC genes Locations [38] 4 In gene, in gene (same strand), gene count, dis-
tance to nearest gene, in exon, in intron
Cellular transcription
Model systems with defined integration sites show
upstream transcription can interfere with viral transcrip-
tion [40] and that cellular transcription in the same ori-
entation may interfere with viral transcription [22] or
increase viral transcription [23] and in opposite orien-
tations may decrease transcription [23]. In integration
site studies, integration outside genes appears to increase
latency [19] but high transcription of nearby host cell
genes may cause increased latency [19,20]. In addition,
Tat or other viral proteins may affect cellular transcription
[41,42].
To look at transcription and latency, we ran a logistic
regression of silent/inducible status on a quartic func-
tion of RNA expression, as determined by RNA-Seq reads
within 5,000 bases in Jurkat cells for the Jurkat sample or
CD4+ T cells for the remaining samples, interacted with
indicator variables encoding cell culture model. There
appears to be little agreement between samples (Figure 3).
The Resting CD4+ and Active CD4+ datasets show an
enrichment in silent proviruses in regions with low gene
expression. The other three studies show the opposite
or no relationship for low expression regions. The two
samples showing increased silence in areas of low expres-
sion (Resting CD4+ and Active CD4+) are from a study
that did not check whether inactive viruses could be acti-
vated. One possible explanation is that regions with low
gene transcriptionmay harbor proviruses that are not eas-
ily activated, though some other discrepancy between in
vitro systems could also explain the difference. Both the
Jurkat and Active CD4+ samples appear to increase in
latency with increasing expression while the remaining
three studies did not show a strong trend.
Orientation bias
Shan et al. [20] reported that inducible proviruses were
oriented in the same strand as the host cell genes into
which they had integrated more often than chance. This
orientation bias was still reproduced after our reprocess-
ing of the Bcl-2 transduced CD4+ sample from Shan et al.
[20]. However, the proportion of provirus oriented in the
same strand as host genes did not differ significantly from
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Figure 1 Correlations of genomic features and latency. Spearman rank correlation between proviral expression status and genomic features.
Only genomic features with at least one correlation with latency with a false discovery rate q-value < 0.01 (marked by asterisks) are shown.
50% in the other samples (Figure 4). Perhaps orienta-
tion bias and transcriptional interference are especially
sensitive to parameters of the model system.
Gene deserts
Lewinski et al. [19] reported increased latency in gene
deserts. In the collected data, integration outside known
genes was associated with latency (Fisher’s exact test, p <
10−6). This seemed to largely be driven by the Active
CD4+ and Resting CD4+ samples with significant associ-
ation found individually in only those two samples (both
p < 10−8) and no significant association observed in the
other three samples (Figure 5A). Looking only at integra-
tion sites outside genes, silent sites in the Resting CD4+
sample had a mean distance to the nearest gene 2.5 times
greater than that of expressed sites (95% CI: 2.2–6.2×, p <
10−6, Welch two sample t-test on log transformed dis-
tance) (Figure 5B). The Active CD4+ sample had a small
difference that did not survive Bonferroni correction.
Lewinski et al. [19] also reported decreased latency near
CpG islands and reasoned this was tied to the increased
latency in gene deserts. In the Resting CD4+ sample,
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Figure 2 Lasso regressions predicting latency.Misclassification error from cross validation for lasso regressions of silent/inducible status on
genomic features as a function of λ, the regularization coefficient for the lasso regression, for all cell culture models combined (A) and each
individual cell culture model (B-F). The number of variables included and size of coefficients in the model increases to the left. Whiskers show the
standard error of mean misclassification error. Dashed vertical lines indicate the minimummisclassification error and the simplest model within one
standard error. Dotted horizontal line indicates the misclassification error expected from random guessing.
silent sites were on average further from CpG islands than
expressed sites (Bonferroni corrected Welch’s two sample
T test, p = 0.006), but there was no significant relation-
ship between silent/inducible status and log distance to
CpG island after Bonferroni correction if the integration
site’s location inside or outside of a gene was accounted
for first (analysis of deviance).
Alphoid repeats
Alphoid repeats are repetitive DNA sequences found
largely in the heterochromatin of centromeres [43]. Inte-
gration near heterochromatic alphoid repeats has been
reported to associate with latency [14,19,21]. Looking only
at uniquely mapping sites, there was no statistically signif-
icant association between latency and location inside an
alphoid repeat in pooled or individual samples (Fisher’s
exact test).
Since alphoid repeats are both problematic to assem-
ble in genomes and difficult to map onto, we reasoned
that some alphoid hits might be lost or miscounted
in the filtering procedures of the standard workup. To
counteract this, we treated each sequence read as an
independent observation of a proviral integration and
included sequence reads with more than one best scor-
ing alignment. For multiply aligned reads, we considered
the read to have been inside an alphoid repeat if any
of its best scoring alignments fell within a repeat. We
found 74 reads with potential alphoid mappings. Integra-
tion inside alphoid repeats was significantly associated
with the expression status of a provirus in the Rest-
ing CD4+, Jurkat and Central Memory CD4+ datasets
(Bonferroni corrected Fisher’s exact test, all p < 0.05) and
approached significance in the Active CD4+ dataset (p =
0.053) (Figure 6). The Bcl-2 transduced CD4+ data did not
contain any integration sites in alphoid repeats, probably
due to 1) the relatively low number of integration sites in
the dataset and 2) to the requirement for cleavage at two
Pst1 restriction sites, which are not found in the consensus
sequence of alphoid repeats [44]. Of the 1340 repeat types
in the RepeatMasker database [44], only alphoid repeats
achieved a significant association with proviral expression
in more than two datasets.
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Figure 3 Cellular expression and latency. Predictions from a logistic regression of silent/inducible status on cellular RNA expression. High y-axis
values are predicted to be silent/inducible. Dotted line shows where equal odds of silent/inducible and expressed are predicted. Solid lines show
predictions from the regression for each sample and shaded regions indicate one standard error from the modeled predictions.
Acetylation
Histone marks or chromatin remodeling, especially
involving the key “Nuc-1” histone near the transcription
start site in the viral LTR, appear to affect viral expres-
sion [15,45,46]. Based on this effect, histone deacety-






























































Figure 4 Strand orientation and latency. The proportion of
provirus integrated in the opposite strand compared to cellular genes
in silent/inducible (blue) and expressed (red) samples. Error bars show
the 95% Clopper-Pearson binomial confidence interval. Dotted line
shows the 0.5 proportion expected by chance.
treatments and show some promise in disrupting latency
[27]. In these genome-wide datasets, we do not have infor-
mation on the state of individual LTR nucleosomes. How-
ever, repressive chromatin does seem to spread to nearby
locations if not blocked by insulators [11,12] and the state
of neighboring chromatin could affect proviral transcrip-
tion independently of provirus-associated histones.
We found that the number of ChIP-seq reads near an
integration site from several histone acetylation marks
(Figure 1) were associated with efficient expression in
the Active CD4+, Resting CD4+ and Central Memory
CD4+ samples. H4K12ac had the strongest association
(Bonferroni corrected Fisher’s method combination of
Spearman’s ρ, p<10−25) with silence/latency (Figure 7A).
Although the appearance of several significantly associ-
ated acetylation marks might suggest acetylation exerts a
considerable effect on the expression of a provirus, there
are strong correlations among these marks, so their effects
may not be independent. To account for the correlations
between these variables, we performed a principal compo-
nent analysis (PCA) to convert the correlated acetylation
marks into a series of uncorrelated principal components
that capture much of the variance within a few com-
ponents. Here, the first principal component explained
59% of the variance and the first ten components 84%.
Several of these principal components again displayed sig-
nificant associations with latency in the Active CD4+,
Resting CD4+ and Central Memory CD4+ samples but
no significant correlations in the Bcl-2 transduced CD4+
or Jurkat samples (Figure 7B). A logistic regression of
expression status on the first ten principal components











































































































Figure 5 Genes and latency. (A) The proportion of provirus integrated outside genes in silent/inducible (blue) and expressed (red) samples. Error
bars show the 95% Clopper-Pearson binomial confidence interval. (B) The nearest distance to any gene for integration sites (points) outside genes
in the five samples. Points are spread in proportion to kernel density estimates. Horizontal lines indicate sample means where there was a significant
difference in means between silent/inducible and expressed provirus (black) or no significant difference (grey).
and sample did not reduce misclassification error from a
base model including only sample in 480-fold cross val-
idation (base model misclassification error: 36.4%, PCA
model: 36.5%). This suggests that acetylation of neighbor-


























































Figure 6 Alphoid repeats and latency. The proportion of
integration sites with matches in alphoid repeats in silent/inducible
(blue) and expressed (red) cells in five samples. Error bars show the
95% Clopper-Pearson binomial confidence interval. Asterisks indicate
significant associations between integrations within an alphoid
repeat and proviral expression status (Bonferroni corrected Fisher’s
exact test p < 0.05).
Clustering
We reasoned that if there was a strong relationship
between latency and chromosomal position, then integra-
tion sites that are near one another on the same chro-
mosome should share the same expression status more
often than expected by chance. To test this, we compared
how often pairs of proviruses shared the same expres-
sion status in relation to the distance between the two
sites (Figure 8). Pairs of sites with little distance between
integration locations did share the same expression sta-
tus more often than expected by chance (e.g. neighbors
closer than 100 bp, Fisher exact test p = 0.0002). Break-
ing out the data to separate between sample and within
sample pairings showed that this matching was limited to
neighbors within the same experimental model (Figure 8),
emphasizing that chromosomal environment does appear
to influence latency, but the factors involved differ among
experimental models of latency.
Discussion
Here we compared the latency status of HIV-1 proviruses
in fivemodel systemswith the genomic features surround-
ing their integration sites. Surprisingly, no relationships
between genomic features near the integration location
and latency achieved significance in all models. Proviruses
from the same cellular model integrated in nearby posi-
tions did share the same latency status much more often
than predicted by chance, indicating the existence of local
features influencing latency, but these were not consistent
among models. This suggests that whatever features are
affecting latency are highly local and model-specific, and
that we may not have access to all relevant chromosomal
features (e.g. [47-50]).
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Figure 7 Acetylation and latency. (A) The number of ChIP-seq reads for H4K12ac, the histone mark with the lowest Fisher’s method p-value for
correlation with latency, within 50,000 bases across the five samples. Integration sites (points) are spread in proportion to kernel density estimates.
Horizontal lines indicate sample means where there was a significant difference (black) in means between silent/inducible and expressed provirus
or no significant difference (grey). (B) The correlation (points) and its 95% confidence interval (vertical lines) between principal components of
acetylation and silent/inducible status for each of the five samples. Red indicates correlations with a Bonferroni-corrected p-value < 0.05.
Figure 8 Shared expression status between near neighbors. The
ratio of the number of pairs of proviruses with matching expression
status to the number of matches expected by random pairings given
the frequency of silent/inducible proviruses. All possible pairs of
proviruses integrated within a given distance of each other on the
same chromosome (red line) were separated into two sets; one with
both proviruses from within the same cell culture model and one
with proviruses paired between two different cell culture models
(black lines). The shaded region shows the 95% Clopper-Pearson
binomial confidence interval for within and between sample pairings.
The dashed horizontal line shows the ratio of 1 expected if there is no
association between the expression status of neighboring proviruses.
In addition to differences in experimental conditions,
methodological issues have the potential to obscure pat-
terns. Examples include multiply infected cells, inacti-
vated viruses and inaccurate assessment of HIV gene
activity—each of these are discussed below.
A latent provirus integrated into the same cell as
an expressed provirus will be erroneously sorted as
expressed, potentially confounding analysis. A low mul-
tiplicity of infection (MOI) will help to avoid this prob-
lem, but there is still the potential for a significant
proportion of the cells studied to contain multiple inte-
grations. This problem arises because although cells
with multiple integrations form a small proportion of
total cells, most of the total are cells lacking an inte-
grated provirus and thus are excluded by experimental
design. For example, assuming integrations are Poisson
distributed with an MOI of 0.1 (1 integration per 10 cells),
90.5% of cells will not contain a provirus, 9% of cells will
contain one proviral integration and 0.5% of cells will con-
tainmultiple integrations. The cells without an integration
are not amplified by HIV-targeted PCR leaving only 9.5%
of the total cells. Of these cells actually under study, 4.9%
will contain multiple integrations. Thus the signal from
expressed proviruses may be muted by the presence of
latent proviruses in the expressed population.
The replication cycle of HIV is error prone, and a sig-
nificant proportion of virions contain mutated genomes
[51]. In studies that do not check for inducibility, mutant
proviruses integrated in regions of the genome other-
wise favorable to proviral expression can be sorted into
the latent pool due to mutational inactivation. This prob-
lem of inactivated provirus is worse when latent provirus
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are rare and exacerbated further when looking at latency
in the cells of HIV patients due to selective enrichment
of inactivated proviruses incapable of spreading infection
[2]. Here, the effects of mutation are minimized in the
datasets that required inducible viral expression (Jurkat,
Bcl-2 transduced CD4+, Central Memory CD4+) but may
be a confounder in the two datasets that were sorted
based on lack of viral expression only (Active CD4+,
Resting CD4+).
Inaccurate staining or leaky markers may also result
in misclassification of proviruses. False positives and
false negatives will result in incorrectly sorted latent and
expressed integrations. For example, if 5% of cells not con-
taining Gag are labeled as Gag+ and there are an equal
amount of latent and expressed integration sites, then
4.8% of integrations labeled expressed will actually be
latent. If a category is rare, false staining has even greater
potential to cause error. For example, if only 5% of sites
are latent and a Gag stain has a false negative rate of 5%,
then we would expect 48.7% of sites classified as latent to
actually be mislabeled expressed integrations.
Attempts to induce latent proviruses in patients have
so far focused on using histone deacetylase inhibitors,
raising interest in associations with histone acetylation
in these data. An important caveat in results from these
genome-wide data is that histone modification near the
integrated provirus may not be representative of modifi-
cation within the provirus at the key “Nuc-1” nucleosome
of the transcription start site [46], though local correla-
tions in chromatin states are well established from stud-
ies of position effect variegation [11,12]. We found that
some histone acetylation marks were significantly asso-
ciated with viral expression in some but not all samples
(Figures 1 and 7). This lack of association may be due
to a lack of power in these studies, but the confidence
intervals suggest that any correlations between acetyla-
tions and latency are unlikely to be strong. These weak
correlations raise the possibility that there are populations
of latent proviruses that are not associated with acety-
lation and may not be inducible by histone deacetylase
inhibitors.
Conclusions
This study highlights that the choice of model system can
have a large effect on measurements of latency. Further
studies are needed to determine which in vitro models
best reflect latency in vivo. Different cell culture mod-
els may report genuinely different mechanisms of latency.
While we did see some relationship between histone
acetylation and latency, paralleling a recent clinical trial
of SAHA [27], associations with histone acetylation did
not explain a large fraction of the difference between
latent and expressed proviruses in any of the five mod-
els. One possible explanation is that there may be multiple
mechanisms that maintain proviruses in a latent state.
To be successful, shock-and-kill treatments must induce
and destroy all latent proviruses to eliminate HIV from
an infected individual, raising the question of whether
multiple simultaneous inducing treatments will be
necessary.
Availability of supporting data
Sequence reads from the Central Memory CD4+ sample
reported here, the Resting CD4+ and Active CD4+ data
reported by Pace et al. [21], the Bcl-2 transduced CD4+
data reported by Shan et al. [20] and reprocessed data
originally reported by Lewinski et al. [19] are available




Naive CD4+ T cells were purified by negative selec-
tion from peripheral blood mononuclear cells. The cells
were activated with anti-CD3 and anti-CD28 (+TGF-beta,
anti-IL-12, and anti-IL-4) to generate “non-polarized”
cells (the in vitro equivalent of central memory T cells).
Five days after isolation, cells were infected with an
NL4-3-based virus with GFP in place of Nef and the
LAI envelope (X4) provided in trans at a concentra-
tion of 500 ng of p24 as measured by ELISA per mil-
lion cells. Based on previous experience with this model,
this amount of p24 should produce an MOI of approxi-
mately 0.15. Cells were cultured in the presence of IL-2.
Two days post-infection, cells were sorted for GFP+; this
active population expresses GFP even when treated with
flavopiridol, although for this study they were not treated.
The inducible population was the set of GFP negative cells
from the initial sort that, 9 days post-infection, were acti-
vated with anti-CD3 and anti-CD28 and sorted for GFP
production.
Genomic DNA from the inducible and expressed pop-
ulations was digested with MseI, ligated to an adapter,
and amplified by ligation-mediated PCR essentially as in
Wu et al. [52] and Mitchell et al. [53] except that the
nested PCR primers included sequence for the Ion Tor-
rent P1 adapter and adapter A sequence with a 5 base
barcode sequence specific to the inducible or expressed
conditions. Amplicons were sequenced using an Ion Tor-
rent Personal Genome Machine (PGM) according to
manufacturer’s instructions using an Ion 316 chip and
the Ion PGM 200 Sequencing kit (Life Technologies).
The sequence reads were sorted into samples by bar-
code. All reads were required to match the expected
5′ sequence with a Levenshtein edit distance less than
3 from the expected barcode, 5′ primer and HIV long
terminal repeat (LTR). The 5′ primer and HIV sequence,
along with the 3′ primer if present, were trimmed from
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the read. Sequences with less than 24 bases remain-
ing or containing any eight base window with an aver-
age quality less than 15 were discarded. Duplicate reads
and reads forming an exact substring of a longer read
were removed.
Previously published data
We collected integration sites from three previously
reported studies (Table 1), for a total of four expressed ver-
sus silent/inducible pairs of samples. These studies used
primary CD4+ T cells or Jurkat cells infected with HIV or
HIV-derived constructs as cell culture models of latency.
Flow cytometry allowed cells expressing viral encoded
proteins to be sorted from non-expressing cells. In two of
the studies, these non-expressing populations were stim-
ulated to ensure that the provirus could be aroused from
latency. Specific differences in protocol between the study
sets are summarized below.
Jurkat
Lewinski et al. [19] infected Jurkat cells with a VSV-
G pseudotyped, GFP-expressing pEV731 HIV construct
(LTR-Tat-IRES-GFP) [13] at an MOI of 0.1. The cells
were sorted into GFP+ and GFP- two to four days after
infection. GFP+ cells were sorted again two weeks after
infection and cells that were again GFP+ were collected
for integration site sequencing. GFP- cells were sorted for
GFP negativity twice more then stimulated with TNFal-
pha. Cells that were GFP+ after stimulation were collected
for integration site sequencing. DNA was digested with
MseI or a combination of NheI, SpeI and XbaI, ligated
to adapters for nested PCR, amplified and sequenced by
Sanger capillary electrophoresis.
Bcl-2 transduced CD4+
Shan et al. [20] transduced CD4+ T cells with Bcl-2, cos-
timulated with bound anti-CD3 and soluble anti-CD28
antibodies, interleukin-2 and T cell growth factor and
then infected with X4-pseudotyped GFP-expressing NL4-
3-6-drEGFP construct [54] at an MOI of less than 0.1.
DNA was extracted, digested with PstI and circularized
[55]. HIV-human junctions were amplified by reverse PCR
and sequenced using Sanger capillary electrophoresis.
Active CD4+ & Resting CD4+
Pace et al. [21] spinoculated CD4+ T cells with HIV
NL4-3 at an MOI of 0.1. After 96 hours, the cells
were stained for intracellular Gag CD25, CD69 and
HLA-DR and sorted into four subpopulations based on
activation state and Gag expression; activated Gag-, acti-
vated Gag+, resting Gag- and resting Gag+. The abil-
ity of the viruses to reactivate was not tested although
previous studies have shown that the majority are
likely inducible [30]. Genomic DNA was extracted and
digested with restriction enzymes MseI and Tsp509 and
ligated to adapters. Proviral LTR-host genome junc-
tions were sequenced by 454 pyrosequencing after
nested PCR.
Alignment
All datasets were processed using the hiReadsProcessor
R package [56]. Adaptor trimmed reads were aligned to
UCSC freeze hg19 using BLAT [57]. Genomic alignments
were scored and required to start within the first three
bases of a read with 98% identity. Alignments for a given
read with a BLAT score less than the maximum score for
that readwere discarded. Reads giving rise tomultiple best
scoring genomic alignments were excluded, while reads
with a single best hit were dereplicated and converged if
within 5 bp of each other. The Bcl-2 transduced CD4+
sample was sequenced from U3 in the 5′ HIV LTR while
the other samples were sequenced from U5 in the 3′
LTR. To account for the 5 base duplication of host DNA
caused by HIV integration, the chromosomal coordinates
of the Bcl-2 transduced CD4+ sample were adjusted by±4
bases.
To allow for alignment difficulties in the analysis of
genomic repeats, reads with multiple best scoring align-
ments, along with the single best hit reads used above,
were included in the repeat analyses. If any best scoring
alignment for a read fell within a repeat, then that read
was considered to map to that repeat.
Genomic features
A total of 140 whole genome features for CD4+ T-cells
were gathered from data sources indicated in Table 2. For
features encoded as peaks or hotspots, the log of the dis-
tance of each integration site to the nearest border was
used for modeling. Integration sites from HIV 89.6 infec-
tion in primary CD4+ T cells (unpublished data) were
used to count nearby integrations and determine a ±20
bp position weight matrix for integration targets. Illumina
RNA-Seq from active CD4+ cells (unpublished data) was
used to estimate raw cellular expression and fragments per
kilobase of transcript per million mapped reads for genes
as calculated by Cufflinks [58]. For sequence-based data
like RNA-Seq and ChIP-Seq, the number of reads aligned
within a ± 50, 500, 5,000 50,000 and 500,000 bp windows
of each integration site were counted and log transformed.
In addition, chromatin state classifications derived from
a hidden Markov model based on histone marks and a
few binding factors [59] were included as binary variables.
All data from previous genomic freezes were converted to
hg19 using liftover [60].
Analysis
All statistical analysis was performed in R 2.15.2 [61].
The analyses are described in a reproducible report
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(Additional file 1). The annotated integration site data
necessary to perform the analyses (Additional files
2 and 3) and the compilable code (Additional file 4) to
generate this reproducible report are provided as supple-
mental information. The newCentralMemory CD4+ data
set was analyzed as in Berry et al. [62] (Additional file 5).
The integration patterns appeared similar to previously
reported HIV integration site datasets [63].
Additional files
Additional file 1: Summary of statistical analyses. A pdf file showing
the R code used for statistical analysis.
Additional file 2: Integration locations and surrounding genomic
features. A gzipped csv file containing all uniquely mapped integration
sites and measures of the genomic features surrounding the integration
sites.
Additional file 3: Integration locations and repeats. A gzipped csv file
containing integration sites with single and multiple genomic alignments
and whether any of those alignments fell within genomic repeats.
Additional file 4: Compilable summary of statistical analyses. A
Sweave Rnw file that can be compiled with R, LaTeX and the data from
Additional files 2 and 3 to generate Additional file 1.
Additional file 5: Genomic feature analysis of Central Memory CD4+
and Bcl-2 transduced CD4+ data. A pdf file reporting the association of
genomic features with integrations in the Central Memory CD4+ and Bcl-2
transduced CD4+ datasets following the methods of Berry et al. [62].
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